Financhill
Buy
55

WBD Quote, Financials, Valuation and Earnings

Last price:
$28.77
Seasonality move :
-1.58%
Day range:
$28.52 - $28.78
52-week range:
$7.52 - $30.00
Dividend yield:
0%
P/E ratio:
153.25x
P/S ratio:
1.88x
P/B ratio:
1.98x
Volume:
19.9M
Avg. volume:
24.1M
1-year change:
160.42%
Market cap:
$71.3B
Revenue:
$39.3B
EPS (TTM):
$0.19
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Revenue $10.6B $12.2B $33.8B $41.3B $39.3B
Revenue Growth (YoY) -4.43% 14.53% 177.51% 22.22% -4.92%
 
Cost of Revenues $5.2B $6.2B $27.7B $32.5B $30B
Gross Profit $5.4B $6B $6.2B $8.8B $9.3B
Gross Profit Margin 50.93% 49.11% 18.21% 21.33% 23.62%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $2.7B $4B $9.7B $9.7B $9.3B
Other Inc / (Exp) -$354M $75M -$3.8B -$935M -$9.6B
Operating Expenses $2.7B $3.9B $8.5B $9.4B $9B
Operating Income $2.7B $2.1B -$2.3B -$610M $279M
 
Net Interest Expenses $692M $673M $1.8B $2.3B $2B
EBT. Incl. Unusual Items $1.7B $1.4B -$9B -$3.9B -$11.4B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $373M $236M -$1.7B -$784M $94M
Net Income to Company $1.4B $1.2B -$7.3B -$3.1B -$11.5B
 
Minority Interest in Earnings $136M $175M $74M $47M -$171M
Net Income to Common Excl Extra Items $1.4B $1.2B -$7.3B -$3.1B -$11.5B
 
Basic EPS (Cont. Ops) $2.14 $1.80 -$3.82 -$1.28 -$4.62
Diluted EPS (Cont. Ops) $1.80 $1.53 -$3.82 -$1.28 -$4.62
Weighted Average Basic Share $510M $507M $1.9B $2.4B $2.5B
Weighted Average Diluted Share $677M $668M $1.9B $2.4B $2.5B
 
EBITDA $4.1B $3.6B $4.9B $7.4B $7.3B
EBIT $2.7B $2.1B -$2.3B -$610M $279M
 
Revenue (Reported) $10.6B $12.2B $33.8B $41.3B $39.3B
Operating Income (Reported) $2.7B $2.1B -$2.3B -$610M $279M
Operating Income (Adjusted) $2.7B $2.1B -$2.3B -$610M $279M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $3.1B $9.8B $10B $9.6B $9.1B
Revenue Growth (YoY) 23.12% 212.2% 1.6% -3.78% -5.71%
 
Cost of Revenues $1.9B $7.9B $7.3B $6.9B $5.9B
Gross Profit $1.3B $2B $2.7B $2.7B $3.1B
Gross Profit Margin 40.58% 19.92% 27.01% 27.73% 34.39%
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $944M $2.6B $2.3B $2.4B $2.4B
Other Inc / (Exp) $56M -$1.7B -$391M -$28M --
Operating Expenses $944M $2.5B $2.3B $2.4B $2.3B
Operating Income $333M -$573M $435M $303M $791M
 
Net Interest Expenses $159M $560M $580M $498M $572M
EBT. Incl. Unusual Items $233M -$2.9B -$532M -$178M $27M
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $36M -$566M -$125M -$319M $170M
Net Income to Company $197M -$2.3B -$407M $141M -$143M
 
Minority Interest in Earnings $41M $23M $10M $6M $5M
Net Income to Common Excl Extra Items $197M -$2.3B -$407M $141M -$143M
 
Basic EPS (Cont. Ops) $0.27 -$0.95 -$0.17 $0.06 -$0.06
Diluted EPS (Cont. Ops) $0.24 -$0.95 -$0.17 $0.05 -$0.06
Weighted Average Basic Share $506M $2.4B $2.4B $2.5B $2.5B
Weighted Average Diluted Share $663M $2.4B $2.4B $2.5B $2.5B
 
EBITDA $674M $1.7B $2.4B $2.1B $2.2B
EBIT $333M -$573M $435M $303M $791M
 
Revenue (Reported) $3.1B $9.8B $10B $9.6B $9.1B
Operating Income (Reported) $333M -$573M $435M $303M $791M
Operating Income (Adjusted) $333M -$573M $435M $303M $791M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Revenue $11.9B $26B $42B $39.6B $37.9B
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $6.1B $20.1B $33.7B $30.8B $27.2B
Gross Profit $5.8B $5.9B $8.4B $8.8B $10.7B
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $3.8B $8.2B $9.8B $9.5B $9.3B
Other Inc / (Exp) $251M -$2.5B -$2.2B -$9.1B --
Operating Expenses $3.8B $7.1B $9.5B $9.3B $9B
Operating Income $2B -$1.3B -$1.1B -$486M $1.6B
 
Net Interest Expenses $652M $1.4B $2.3B $2.1B $2B
EBT. Incl. Unusual Items $1.7B -$6.2B -$5.8B -$11.6B $1.7B
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense $242M -$1.1B -$1B -$411M $1.3B
Net Income to Company $1.4B -$5.1B -$4.8B -$11.2B $356M
 
Minority Interest in Earnings $182M $89M $61M -$17M -$129M
Net Income to Common Excl Extra Items $1.4B -$5.1B -$4.8B -$11.2B $356M
 
Basic EPS (Cont. Ops) $2.20 -$1.66 -$1.98 -$4.58 $0.19
Diluted EPS (Cont. Ops) $1.86 -$1.68 -$1.98 -$4.58 $0.19
Weighted Average Basic Share
Weighted Average Diluted Share
 
EBITDA $3.4B $4.3B $7B $6.9B $7.7B
EBIT $2B -$1.3B -$1.1B -$486M $1.6B
 
Revenue (Reported) $11.9B $26B $42B $39.6B $37.9B
Operating Income (Reported) $2B -$1.3B -$1.1B -$486M $1.6B
Operating Income (Adjusted) $2B -$1.3B -$1.1B -$486M $1.6B
Period Ending 2022-09-30 2023-09-30 2024-09-30 2025-09-30 2026-09-30
Revenue $22.8B $31B $29.3B $27.8B --
Revenue Growth (YoY) -- -- -- -- --
 
Cost of Revenues $18.5B $24.6B $22.8B $20B --
Gross Profit $4.3B $6.5B $6.4B $7.8B --
Gross Profit Margin -- -- -- -- --
 
R&D Expenses -- -- -- -- --
Selling, General & Admin $7.2B $7.2B $7.1B $7B --
Other Inc / (Exp) -$2.4B -$864M -$9.1B -$137M --
Operating Expenses $6B $7B $6.9B $6.9B --
Operating Income -$1.8B -$572M -$446M $934M --
 
Net Interest Expenses $1.2B $1.7B $1.5B $1.5B --
EBT. Incl. Unusual Items -$6.4B -$3.3B -$11B $2B --
Earnings of Discontinued Ops. -- -- -- -- --
Income Tax Expense -$1.2B -$563M -$190M $1.1B --
Net Income to Company -$5.2B -$2.7B -$10.8B $996M --
 
Minority Interest in Earnings $52M $39M -$25M $17M --
Net Income to Common Excl Extra Items -$5.2B -$2.7B -$10.8B $996M --
 
Basic EPS (Cont. Ops) -$1.76 -$1.12 -$4.42 $0.39 --
Diluted EPS (Cont. Ops) -$1.76 -$1.12 -$4.42 $0.39 --
Weighted Average Basic Share $5.3B $7.3B $7.3B $7.4B --
Weighted Average Diluted Share $5.4B $7.3B $7.4B $7.4B --
 
EBITDA $3.3B $5.4B $4.9B $5.3B --
EBIT -$1.8B -$572M -$446M $934M --
 
Revenue (Reported) $22.8B $31B $29.3B $27.8B --
Operating Income (Reported) -$1.8B -$572M -$446M $934M --
Operating Income (Adjusted) -$1.8B -$572M -$446M $934M --
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Cash and Equivalents $2.4B $4B $4B $4.4B $5.5B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.5B $2.4B $7.6B $7.3B $5.9B
Inventory $532M $245M -- -- --
Prepaid Expenses -- -- -- $843M $784M
Other Current Assets $1.5B $913M $2.1B $2.3B $2.1B
Total Current Assets $6.1B $7.3B $14B $14.2B $14.1B
 
Property Plant And Equipment $1.8B $1.9B $8.5B $9B $8.5B
Long-Term Investments $1.4B $1.5B $2B $1.8B $1.5B
Goodwill $13.1B $12.9B $34.4B $35B $25.7B
Other Intangibles $11.1B $10.1B $71.6B $59.5B $51.4B
Other Long-Term Assets $2.1B $2.8B $8.6B $8.1B $7.3B
Total Assets $34.1B $34.4B $134B $122.8B $104.6B
 
Accounts Payable $397M $412M $1.5B $1.3B $1.1B
Accrued Expenses $1.3B $2.2B $8.4B $8.3B $10.4B
Current Portion Of Long-Term Debt $335M -- -- $1.8B $2.7B
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.1B $3.5B $15B $15.3B $15.8B
 
Long-Term Debt $15.8B $15.2B $51.8B $45.1B $39.8B
Capital Leases -- -- -- -- --
Total Liabilities $21.7B $21B $85.3B $76.3B $69.6B
 
Common Stock $7M $7M $27M $27M $27M
Other Common Equity Adj -$651M -$830M -$1.5B -$741M -$1.1B
Common Equity $10.5B $11.6B $47.1B $45.2B $34B
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.9B $1.8B $1.6B $1.2B $901M
Total Equity $12.4B $13.4B $48.7B $46.5B $34.9B
 
Total Liabilities and Equity $34.1B $34.4B $134B $122.8B $104.6B
Cash and Short Terms $2.4B $4B $4B $4.4B $5.5B
Total Debt $16.2B $15.6B $52.3B $47B $42.7B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Cash and Equivalents $3.1B $2.5B $2.5B $3.5B $4.3B
Short Term Investments -- -- -- -- --
Accounts Receivable, Net $2.5B $8B $6.3B $5.5B $5.1B
Inventory $254M $149M -- -- --
Prepaid Expenses -- -- -- -- --
Other Current Assets $1.1B $2.3B $4.1B $3.6B --
Total Current Assets $6.7B $12.7B $12.8B $12.5B $13.1B
 
Property Plant And Equipment $1.3B $8.4B $5.8B $6.2B $6.5B
Long-Term Investments $501M $2.3B $1.8B $1.6B $1.5B
Goodwill $13B $34.5B $34.7B $25.9B --
Other Intangibles $10.5B $75B $62.3B $53.8B --
Other Long-Term Assets $2.9B $8.8B $8.1B $8B --
Total Assets $34.3B $136B $123.7B $106.3B $100.5B
 
Accounts Payable $2.3B $1.5B $1.3B $1.1B $1.1B
Accrued Expenses -- $9.2B $10B $10B --
Current Portion Of Long-Term Debt $349M -- -- $3B --
Current Portion Of Capital Lease Obligations -- -- -- -- --
Other Current Liabilities -- -- -- -- --
Total Current Liabilities $3.3B $14.7B $14.6B $15.7B $12.2B
 
Long-Term Debt $14.4B $51.8B $43.5B $37.2B $33.4B
Capital Leases -- -- -- -- --
Total Liabilities $20.9B $86B $77.6B $70.2B $63.2B
 
Common Stock $7M $27M $27M $27M $27M
Other Common Equity Adj -$717M -$2.1B -$1.4B -$401M --
Common Equity -- -- -- -- --
Total Preferred Equity -- -- -- -- --
Minority Interest, Total $1.8B $1.6B $1.4B $1.1B $1.3B
Total Equity $13.4B $50.1B $46.1B $36.2B $37.3B
 
Total Liabilities and Equity $34.3B $136B $123.7B $106.3B $100.5B
Cash and Short Terms $3.1B $2.5B $2.5B $3.5B $4.3B
Total Debt $14.8B $53.1B $44.8B $40.2B $33.5B
Period Ending 2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31
Net Income to Stockholders $1.4B $1.2B -$7.3B -$3.1B -$11.5B
Depreciation & Amoritzation $1.4B $1.6B $7.2B $8B $7B
Stock-Based Compensation $110M $178M $412M $500M $557M
Change in Accounts Receivable $105M $47M $181M $312M $1B
Change in Inventories -- -- -- -- --
Cash From Operations $2.7B $2.8B $4.3B $7.5B $5.4B
 
Capital Expenditures $402M $373M $987M $1.3B $948M
Cash Acquisitions $39M $2M -- $50M --
Cash From Investing -$703M -$56M $3.5B -$1.3B -$349M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued $2.5B -- $2.4B $6.7B $15.8B
Long-Term Debt Repaid -$2.7B -$574M -$9.7B -$12.1B -$19.2B
Repurchase of Common Stock $969M -- -- -- --
Other Financing Activities -$366M -$279M -$425M -$466M -$323M
Cash From Financing -$1.5B -$853M -$7.7B -$5.8B -$3.7B
 
Beginning Cash (CF) $2.1B $3.9B $3.9B $4.3B $5.4B
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $570M $1.8B $25M $389M $1.1B
Ending Cash (CF) $2.8B $5.6B $3.9B $4.7B $6.3B
 
Levered Free Cash Flow $2.3B $2.4B $3.3B $6.2B $4.4B
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $197M -$2.3B -$407M $141M -$143M
Depreciation & Amoritzation $341M $2.2B $2B $1.8B $1.4B
Stock-Based Compensation $39M $107M $143M $159M $242M
Change in Accounts Receivable $185M $305M $400M $708M $260M
Change in Inventories -- -- -- -- --
Cash From Operations $811M $124M $2.5B $847M $979M
 
Capital Expenditures $106M $316M $457M $215M $278M
Cash Acquisitions -- -- -- -- --
Cash From Investing -$226M $862M -$458M -$218M -$298M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued -- $795M $1.7B $2.6B --
Long-Term Debt Repaid -$235M -$3.3B -$4.1B -$3.4B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$38M $187M -$210M -$28M --
Cash From Financing -$273M -$2.3B -$2.6B -$875M -$1.3B
 
Beginning Cash (CF) $3.1B $2.5B $2.4B $3.5B $4B
Foreign Exchange Rate Adjustment -$20M -$56M -$80M $119M -$5M
Additions / Reductions $292M -$1.4B -$647M -$127M -$593M
Ending Cash (CF) $3.4B $1.1B $1.7B $3.5B $3.4B
 
Levered Free Cash Flow $705M -$192M $2.1B $632M $701M
Period Ending 2021-09-30 2022-09-30 2023-09-30 2024-09-30 2025-09-30
Net Income to Stockholders $1.4B -$5.1B -$4.8B -$11.2B $356M
Depreciation & Amoritzation $1.4B $5.6B $8.1B $7.4B $6B
Stock-Based Compensation $182M $361M $486M $528M $678M
Change in Accounts Receivable -$7M -$136M $287M $862M $295M
Change in Inventories -- -- -- -- --
Cash From Operations $2.5B $2.3B $6.7B $6.2B $5.2B
 
Capital Expenditures $385M $723M $1.4B $930M $1.1B
Cash Acquisitions $44M -$29M -- $50M --
Cash From Investing -$214M $3.7B -$1.2B -$589M -$122M
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid
Long-Term Debt Issued -- $885M $7.3B $16.7B --
Long-Term Debt Repaid -$574M -$7.2B -$12.5B -$20.9B --
Repurchase of Common Stock $228M -- -- -- --
Other Financing Activities -$286M -$185M -$412M -$552M --
Cash From Financing -$1.1B -$6.5B -$5.6B -$4.7B -$4.4B
 
Beginning Cash (CF) -- -- -- -- --
Foreign Exchange Rate Adjustment -- -- -- -- --
Additions / Reductions $1.2B -$613M -$83M $1.1B $808M
Ending Cash (CF) -- -- -- -- --
 
Levered Free Cash Flow $2.1B $1.6B $5.3B $5.3B $4.1B
Period Ending 2022-09-30 2023-09-30 2024-09-30 2025-09-30 2026-09-30
Net Income to Stockholders -$5.2B -$2.7B -$10.8B $996M --
Depreciation & Amoritzation $5B $6B $5.4B $4.4B --
Stock-Based Compensation $317M $391M $419M $540M --
Change in Accounts Receivable -$139M -$33M $517M -$200M --
Change in Inventories -- -- -- -- --
Cash From Operations $1.5B $3.9B $2.7B $2.5B --
 
Capital Expenditures $623M $1B $662M $810M --
Cash Acquisitions -- -- -- -- --
Cash From Investing $3.7B -$1B -$355M -$128M --
 
Dividends Paid (Ex Special Dividend) -- -- -- -- --
Special Dividend Paid -- -- -- -- --
Long-Term Debt Issued $885M $5.8B $15.8B $2.2B --
Long-Term Debt Repaid -$7.2B -$10B -$18.8B -$4.4B --
Repurchase of Common Stock -- -- -- -- --
Other Financing Activities -$143M -$130M -$216M $270M --
Cash From Financing -$6.5B -$4.3B -$3.1B -$3.8B --
 
Beginning Cash (CF) $10.6B $8.1B $10.5B $12.2B --
Foreign Exchange Rate Adjustment -$122M -$66M $15M $251M --
Additions / Reductions -$1.4B -$1.5B -$829M -$1.1B --
Ending Cash (CF) $9.1B $6.6B $9.7B $11.3B --
 
Levered Free Cash Flow $835M $2.9B $2B $1.7B --

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
55
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 65x

Sell
50
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 35x

Sell
40
Is GOOGL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 29x

Alerts

Buy
77
RNG alert for Feb 21

RingCentral, Inc. [RNG] is up 34.37% over the past day.

Sell
9
FROG alert for Feb 21

JFrog Ltd. [FROG] is down 24.98% over the past day.

Buy
72
SNSE alert for Feb 21

Sensei Biotherapeutics, Inc. [SNSE] is up 23.81% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock